Gross profit increased 27.8%
Gross profit changed +27.8% from the comparable as-filed period.
$1.8B→$2.4B3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit changed +27.8% from the comparable as-filed period.
Gross margin changed +99 basis points from the comparable as-filed period.
Research & development changed +18.4% from the comparable as-filed period.
Selling, general & administrative changed +15.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.